IP Library › Patent Application 18580746

Patent Application

App. No. 18/580,746

ANNULATED PYRIDAZINE COMPOUND

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US None
App. No.: 18/580,746

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

An object of the present invention is to provide a pharmaceutical composition, in particular, a compound suitable for preventing and/or treating inflammatory diseases and/or neurodegenerative disease. The present inventors have conducted intensive studies to find a compound having an inhibitory effect on NLRP3 inflammasome activation and found that an annulated pyridazine compound has an inhibitory effect on NLRP3 inflammasome activation, thus completing the present invention. The annulated pyridazine compound of the present invention is expected to serve as a prophylactic and/or therapeutic agent for inflammatory diseases and/or neurodegenerative diseases.

Claims (108)

1 . A compound of formula (I):

or a salt thereof, wherein

ring A is C 5-8 cycloalkenyl, 5- to 11-membered partially unsaturated heterocyclyl, aryl, or heteroaryl;

R 1 , which are identical or different from each other, are OH, C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, halogen, cyano, —O—C 1-6 alkyl, —O-halogeno C 1-6 alkyl, or —O—C 3-8 cycloalkyl;

R 2 , which are identical or different from each other, are C 1-6 alkyl, —C 1-6 alkylene-aryl, C 3-8 cycloalkyl, halogen, —O—C 1-6 alkyl, —O-halogeno C 1-6 alkyl, oxo, —C(O)—C 1-6 alkyl, or —S(O) 2 —C 1-6 alkyl;

L is —NR 3 —, —O—, or —CR 4 R 5 —;

R 3 is H or C 1-6 alkyl;

R 4 and R 5 , which are identical or different from each other, are H or C 1-6 alkyl;

R 6 is C 1-6 alkyl substituted with one to four identical or different R 7 , —C 1-6 alkylene-(C 3-8 cycloalkyl optionally substituted with one to four identical or different R 8 ), —C 1-6 alkylene-(4- to 7-membered saturated heterocyclyl optionally substituted with one to four identical or different R 9 ), C 3-8 cycloalkyl optionally substituted with one to four identical or different R 10 or 4- to 7-membered saturated heterocyclyl optionally substituted with one to four identical or different R 11 ;

R 7 is —OR 12 , —NR 13 R 14 , halogen, or cyano;

R 8 and R 10 are C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, —OR 12 , —NR 13 R 14 , —C 1-6 alkylene-OR 12 , —C 1-6 alkylene-NR 13 R 14 , halogen, or cyano;

R 9 and R 11 are C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, 4- to 7-membered saturated heterocyclyl, —OR 12 , —NR 13 R 14 , —C 1-6 alkylene-OR 12 , —C 1-6 alkylene-NR 13 R 14 , halogen, cyano, oxo, —C(O)—C 1-6 alkyl, or —S(O) 2 —C 1-6 alkyl;

R 12 is H or C 1-6 alkyl;

R 13 and R 14 , which are identical or different from each other, are H, C 1-6 alkyl, or —C(O)—C 1-6 alkyl;

n is an integer of 1 to 4 and represents the number of substituents R 1 ; and

m is an integer of 0 to 3 and represents the number of substituents R 2 ,

provided that when ring A is aryl or heteroaryl, formula (I) is formula (Ia):

R 1a , which are identical or different from each other, are C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, halogen, cyano, —O—C 1-6 alkyl, —O-halogeno C 1-6 alkyl, or —O—C 3-8 cycloalkyl; and

k is an integer of 0 to 3 and represents the number of substituents R 1a .

2 . The compound or a salt thereof according to claim 1 , wherein

ring A is C 5-8 cycloalkenyl, 5- to 8-membered partially unsaturated heterocyclyl, aryl, or heteroaryl; and

R 2 , which are identical or different from each other, are C 1-6 alkyl, —C 1-6 alkylene-aryl, C 3-8 cycloalkyl, halogen, —O—C 1-6 alkyl, —O-halogeno C 1-6 alkyl, —C(O)—C 1-6 alkyl, or —S(O) 2 —C 1-6 alkyl.

3 . The compound or a salt thereof according to claim 2 , wherein formula (I) is formula (Ia).

4 . The compound or a salt thereof according to claim 3 , wherein ring A is C 5-8 cycloalkenyl or 5- to 8-membered partially unsaturated heterocyclyl.

5 . The compound or a salt thereof according to claim 1 , wherein

formula (I) is formula (Ia);

R 1a , which are identical or different from each other, are C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, halogen, —O—C 1-6 alkyl, or —O-halogeno C 1-6 alkyl;

R 2 , which are identical or different from each other, are C 1-6 alkyl, oxo, —C(O)—C 1-6 alkyl, or —S(O) 2 —C 1-6 alkyl;

L is —NR 3 —, —O—, or —CR 4 R 5 —;

R 3 is H;

R 4 and R 5 are H;

R 6 is C 1-6 alkyl substituted with one R 7 , —C 1-6 alkylene-(C 3-8 cycloalkyl optionally substituted with one R 8 ), —C 1-6 alkylene-(4- to 7-membered saturated heterocyclyl), C 3-8 cycloalkyl optionally substituted with one or two identical or different R 10 , or 4- to 7-membered saturated heterocyclyl optionally substituted with one or two identical or different R 11 ;

R 7 is —OR 12 or —NR 13 R 14 ;

R 8 and R 10 are C 1-6 alkyl, —OR 12 , —NR 13 R 14 , —C 1-6 alkylene-OR 12 , halogen, or cyano;

R 9 and R 11 are C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, 4- to 7-membered saturated heterocyclyl, —OR 12 , oxo, or —C(O)—C 1-6 alkyl;

R 12 is H;

R 13 and R 14 are each H, or R 13 is —C(O)—C 1-6 alkyl, and R 14 is H;

k is an integer of 0 to 2 and represents the number of substituents R 1a ; and

m is an integer of 0 to 2 and represents the number of substituents R 2 .

6 . The compound or a salt thereof according to claim 5 , wherein

ring A is C 5-8 cycloalkenyl or 5- to 11-membered partially unsaturated heterocyclyl;

L is —NR 3 —;

R 6 is C 1-6 alkyl substituted with one R 7 , C 3-8 cycloalkyl optionally substituted with one or two identical or different R 10 , or 4- to 7-membered saturated heterocyclyl optionally substituted with one or two identical or different R 11 ;

R 10 is C 1-6 alkyl, —OR 12 , —NR 13 R 14 , —C 1-6 alkylene-OR 12 , halogen, or cyano; and

R 11 is C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, 4- to 7-membered saturated heterocyclyl, —OR 12 , oxo, or —C(O)—C 1-6 alkyl.

7 . The compound or a salt thereof according to claim 6 , wherein

ring A is C 5-8 cycloalkenyl or 5- to 8-membered partially unsaturated heterocyclyl;

R 1a , which are identical or different from each other, are halogeno C 1-6 alkyl, halogen, or —O-halogeno C 1-6 alkyl;

R 2 is C 1-6 alkyl;

R 6 is C 3-8 cycloalkyl optionally substituted with one or two identical or different R 10 or 4- to 7-membered saturated heterocyclyl optionally substituted with one or two identical or different R 11 ;

R 10 is C 1-6 alkyl or —OR 12 ;

R 11 is C 1-6 alkyl or —OR 12 ;

k is 1 or 2 and represents the number of substituents R 1a ; and

m is 0 or 1 and represents the number of substituents R 2 .

8 . The compound or a salt thereof according to claim 1 , wherein

formula (I) is formula (Ia);

ring A is 5- to 11-membered partially unsaturated heterocyclyl;

R 1a , which are identical or different from each other, are C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, halogen, —O—C 1-6 alkyl, or —O-halogeno C 1-6 alkyl;

R 2 , which are identical or different from each other, are C 1-6 alkyl, oxo, —C(O)—C 1-6 alkyl, or —S(O) 2 —C 1-6 alkyl;

L is —NR 3 —;

R 3 is H;

R 7 is —OR 12 or —NR 13 R 14 ;

R 10 is C 1-6 alkyl, —OR 12 , —NR 13 R 14 , —C 1-6 alkylene-OR 12 , halogen, or cyano; and

R 11 is C 1-6 alkyl, halogeno C 1-6 alkyl, C 3-8 cycloalkyl, 4- to 7-membered saturated heterocyclyl, —OR 12 , oxo, or —C(O)—C 1-6 alkyl;

R 12 is H;

R 13 and R 14 are each H, or R 13 is —C(O)—C 1-6 alkyl, and R 14 is H;

k is an integer of 0 to 2 and represents the number of substituents R 1a ; and

m is an integer of 0 to 2 and represents the number of substituents R 2 .

9 . The compound or a salt thereof according to claim 8 , wherein

formula (I) is formula (If), (Ig), (Ih), (Ii), (Ij), (Iu), (Iv), (Iw), or (Iy):

R 11 is C 1-6 alkyl or —OR 12 ; and

m is 0.

10 . The compound or a salt thereof according to claim 9 , wherein

formula (I) is formula (Ih);

R 10 is C 1-6 alkyl, —OR 12 , or cyano;

R 13 is —C(O)—C 1-6 alkyl, and R 14 is H.

11 . The compound or a salt thereof according to claim 1 , wherein the compound is selected from the group consisting of:

2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-5,6,7,8-tetrahydrophthalazin-1-yl)-5-(trifluoromethyl)phenol;

2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-7,8-dihydro-5H-pyrano[3,4-d]pyridazin-1-yl)-5-(trifluoromethyl)phenol;

2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-7,8-dihydro-5H-pyrano[3,4-d]pyridazin-1-yl)-5-(trifluoromethoxy)phenol;

2-(4-{[(1R,2S)-2-hydroxycyclohexyl]amino}-7,8-dihydro-5H-pyrano[3,4-d]pyridazin-1-yl)-5-(trifluoromethyl)phenol;

2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-5,6,8,9-tetrahydrooxepino[4,5-d]pyridazin-1-yl)-5-(trifluoromethyl)phenol;

5-chloro-2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-7,8-dihydro-5H-pyrano[3,4-d]pyridazin-1-yl)phenol;

2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-6-methyl-5,6,7,8-tetrahydropyrido[3,4-d]pyridazin-1-yl)-5-(trifluoromethyl)phenol;

5-(difluoromethoxy)-2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-5,6,7,8-tetrahydrophthalazin-1-yl)phenol;

5-(difluoromethoxy)-2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-7,8-dihydro-5H-pyrano[3,4-d]pyridazin-1-yl)phenol;

5-(difluoromethoxy)-2-(4-{[(3R)-1-methylpiperidin-3-yl]amino}-7,8-dihydro-5H-pyrano[3,4-d]pyridazin-1-yl)phenol;

2-(4-{[(1R,2R)-2-hydroxycyclohexyl]amino}-5,7-dihydrothieno[3,4-d]pyridazin-1-yl)-5-(trifluoromethyl)phenol; and

5-(difluoromethyl)-2-(4-{[(1R,3S)-3-hydroxycyclohexyl]amino}-5,7-dihydrofuro[3,4-d]pyridazin-1-yl)phenol.

12 . The compound or a salt thereof according to claim 1 , wherein the compound is selected from the group consisting of: